Stock Exchange:
NEW YORK
Sector:
Biotechnology
Sub-sector:
Pharmaceuticals
Turnover last year:
829,3 M$ 2023
Profits last year:
281,6 M$ 2023
Activity: biotechnology.
Halozyme Therapeutics offers solutions to facilitate the delivery of drugs and injected fluids. It licenses its technology to biopharmaceutical companies.
https://halozyme.com/